Company

We are GSK

We discover, develop and deliver medicines and vaccines to create value for patients and shareholders.

Close video

Scroll to explore

Innovation to prevent and treat disease is at the heart of everything we do.

We aim to positively impact the health of 2.5 billion people by the end of the decade.

Our purpose, strategy and culture

GSK at a glance

Research and development

medicines and vaccines in development

Innovation

Getting ahead of disease in

markets worldwide

Careers

Outstanding people

66,800

GSK people

Outstanding people

Responsible business

2nd

in the Access to Medicine Index among 20 of the world's largest pharmaceutical companies

Responsibility

Performance

£32.7bn

group turnover in 2025, AER 4% CER 7%

Investors

Behind the Science

Exploring how today's discoveries are shaping tomorrow's health

‘The roar I hear is the next stage of the rocket firing’: MAPS technology and the new age of vaccine development

Antibody-drug conjugates: Advancing the search for more targeted cancer treatment

Mapping disease at the cellular level: A single-cell revolution in drug discovery

Why adults aged 50 years and older with certain long-term health conditions need to make their move to help protect against this common respiratory virus

'The ever-present threat of contracting a UTI means my daily routine is ruled by measures to reduce my risk'

'We’re innovating to help keep COPD patients out of hospital and exacerbation-free'

'Prevention is the best medicine to stop disease before it starts'

‘I was the sickest anyone could ever be’: Why young people are at risk of meningitis and what needs to change to reduce it

‘Digital biological twins and organoids might sound like sci-fi, but they’re real – and we’re using them to fight cancer’

‘I feel hopeless and frustrated’: Why patients living with incurable blood cancers need more treatment options

Read our magazine